Biotech company on the hunt for a partner at the year's most important conference

Scandion Oncology will meet with several representatives from large and medium-sized businesses at this year's JP Morgan conference. The hope is that the business will meet a future partner.

Nils Brünner, CEO and co-founder of Scandion Oncology is participating in the JP Morgan conference in San Francisco, which is the year's most important conference for the life science industry, for the first time. Photo: Scandion Oncology

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles